Object: To assess the current attitude to Helicobacter pylori infection in
Switzerland, since a review of the literature reveals few publications deal
ing with application of therapeutic recommendations.
Methods: The initial diagnostic methods, the indications for eradication th
erapy, the therapeutic regimen and its duration, together with eradication
control, were indicated in questionnaires sent out to the members of the Sw
iss Society for Gastroenterology and Hepatology at the beginning of 1997.
Results: Helicobacter pylori was diagnosed mainly with a rapid urease test
and/or histology. Peptic ulcer disease (100%), mucosa associated lymphoid t
issue (MALT) lymphoma (94.5%) and therapy-resistant dyspepsia (78.7%) were
clear indications for Helicobacter pylori eradication. Only a minority erad
icated Helicobacter pylori in all positive subjects. 7-day triple therapy (
with proton pump inhibitors, a macrolide antibiotic and an imidazole deriva
tive) is the preferred first line treatment.
Conclusions: The eradication of Helicobacter pylori in ulcer disease is est
ablished practice. Non-ulcer dyspepsia remains a controversial but often us
ed indication. Two antibiotics together with proton pump inhibitors constit
ute the mostly widely used eradication therapy.